March 26, 2020
TULSA-PRO® prostate cancer treatment is now available for Jacksonville patients through Kasraeian Urology's partnership with Vituro Health.
5-year Outcomes Following a HIFU Focal Therapy Study Demonstrate Impressive Disease Control & Low Side Effect Profiles
July 11, 2018
SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to report 5-year outcomes from a multicenter study following focal therapy treatment with its Sonablate technology of 625 medium to high-risk clinically significant non-metastatic prostate cancer patient
April 19, 2018
Vituro Health has created the Medicare Elite Access (MEA) program to allow enhanced access for prostate cancer patients to the most experienced HIFU physicians in the United States. The MEA program is designed to connect a Medicare patient with a Vituro trained HIFU physician and assist the patient with all reimbursement opportunities.
December 20, 2017
Vituro Health Partner Dr. Kassabian was featured on The Weekly Check Up: Atlanta. He joined Dr. Bruce Feinberg to discuss all things prostate cancer and a new treatment option that minimizes side effects.